Please login to the form below

Not currently logged in
Email:
Password:

Takeda files US patent case

Takeda sues Dr Reddy's over patent infringements related to Dexilant drug

Takeda Pharmaceutical has filed a patent infringement suit against India's Dr Reddy's Laboratories in a New York court. The suit relates to efforts from Dr Reddy's to manufacture a generic version of Takeda's acid reflux treatment drug Dexilant (dexlansoprazole).

Takeda alleges that the Indian generic-drug maker and its US subsidiary have infringed US patent numbers through the submission of an abbreviated new drug application seeking approval to market generic versions of Dexilent.

The drug has an annual market size of more than $300m in the US market, according to IMS Health figures.

Dr Reddy's was unavailable for comment at the time of writing.

13th April 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics